Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors
Marta Opalińska, Karolina Morawiec-Sławek, Adrian Kania-Kuc, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE
Victor Santoro-Fernandes, Brayden Schott, Alison Deatsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3428-3439
Closed Access | Times Cited: 5
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
Leandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3483-3483
Open Access | Times Cited: 11
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
Vishnu Murthy, Andrei Gafita, Pan Thin, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 11, pp. 1737-1743
Open Access | Times Cited: 9
Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients With Advanced Neuroendocrine Tumors
Reut Halperin, Amit Tirosh
JCO Oncology Practice (2024) Vol. 20, Iss. 10, pp. 1401-1409
Closed Access | Times Cited: 2
Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT
Hwan Lee, Sarit T. Kipnis, Remy Niman, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 200-200
Open Access | Times Cited: 6
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
Luca Urso, Angelo Castello, Giorgio Treglia, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 606-606
Open Access | Times Cited: 4
Synchronous neuroendocine liver metastases in comparison to primary pancreatic neuroendocrine tumors on MRI and SSR-PET/CT
Annie Horng, Maria Ingenerf, Frank Berger, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
Þorvarður R. Hálfdánarson, Nadine Mallak, Scott Paulson, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4836-4836
Open Access | Times Cited: 3
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM
Maria Ingenerf, H. M. A. Karim, Christoph J. Auernhammer, et al.
Radiology and Oncology (2023) Vol. 57, Iss. 4, pp. 436-445
Open Access | Times Cited: 1
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients
H. M. A. Karim, Michael Winkelmann, Freba Grawe, et al.
Radiology and Oncology (2024) Vol. 58, Iss. 3, pp. 348-356
Open Access
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours
Karolina Morawiec-Sławek, Marta Opalińska, Wioletta Lenda-Tracz, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access
Mid-PRRT Response Predicts Overall Outcome in Patients with Neuroendocrine Neoplasms
Reut Halperin, Amit Tirosh
Research Square (Research Square) (2023)
Open Access
Quarter Century PET/Computed Tomography Transformation of Oncology
Charles Marcus, Saima Muzahir, Rathan M. Subramaniam
PET Clinics (2023) Vol. 19, Iss. 2, pp. 187-196
Closed Access
Page 1

Scroll to top